Tekla Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Tekla Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,543	Closed	-$929K	–	208
2020 Q3	$929K	Hold	6,543	–	–	0.03%	182
2020 Q2	$1.29M	Hold	6,543	–	–	0.05%	185
2020 Q1	$1.28M	Hold	6,543	–	–	0.06%	161
2019 Q4	$1.35M	Sell	6,543 -2,598	-28%	-$480K	0.05%	172
2019 Q3	$1.4M	Sell	9,141 -39,384	-81%	-$6.45M	0.06%	145
2019 Q2	$6.26M	Hold	48,525	–	–	0.26%	83
2019 Q1	$5.71M	Sell	48,525 -51,290	-51%	-$5.17M	0.23%	90
2018 Q4	$9.16M	Hold	99,815	–	–	0.39%	54
2018 Q3	$11.2M	Buy	99,815 +13,000	+15%	+$1.37M	0.41%	58
2018 Q2	$8M	Sell	86,815 -8,820	-9%	-$856K	0.3%	75
2018 Q1	$9.54M	Buy	95,635 +42,435	+80%	+$4.57M	0.37%	59
2017 Q4	$4.99M	Buy	53,200 +34,200	+180%	+$3.24M	0.19%	93
2017 Q3	$1.93M	Hold	19,000	–	–	0.07%	122
2017 Q2	$1.45M	Sell	19,000 -96,738	-84%	-$8.14M	0.05%	123
2017 Q1	$9.97M	Hold	115,738	–	–	0.39%	59
2016 Q4	$7.43M	Sell	115,738 -32,000	-22%	-$1.97M	0.32%	66
2016 Q3	$9.55M	Hold	147,738	–	–	0.37%	64
2016 Q2	$8.2M	Buy	147,738 +127,738	+639%	+$6.42M	0.33%	67
2016 Q1	$836K	Hold	20,000	–	–	0.04%	132
2015 Q4	$1.26M	Hold	20,000	–	–	0.05%	125
2015 Q3	$814K	Hold	20,000	–	–	0.03%	154
2015 Q2	$1.03M	Buy	+20,000	New	+$1.06M	0.04%	107

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tekla Capital Management's LKFT Position: Q4 2020 in Review

Tekla Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2020, closing a stake of 6,543 shares — an estimated $929K sold.

Tekla Capital Management first reported a position in LKFT in Q2 2015 and held it in 22 quarters. The position peaked at $11.2M in Q3 2018. 116 funds tracked by Wall St. Rank hold LKFT as of Q4 2020.

Tekla Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2020 after selling out during the quarter.
Tekla Capital Management sold 6,543 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2020, an estimated $929K.
Tekla Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 22 quarters.
Tekla Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $11.2M in Q3 2018.
116 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2020.

Based on Tekla Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.